Summary

Persistence Market Research has recently released a comprehensive report on the global At-Home Molecular Testing market. The report delivers an in-depth evaluation of key market dynamics-drivers, trends, opportunities, and restraints-while offering detailed insights into market structure, value chain evolution, and competitive positioning across regions.

Key Insights

- At-Home Molecular Testing Market Size (2026E): US$ 16.8 Bn
- Projected Market Value (2033F): US$ 27.6 Bn
- Global Market Growth Rate (CAGR 2026-2033): 6.4%

At-Home Molecular Testing Market - Report Scope

The at-home molecular testing market encompasses diagnostic kits enabling self-administered molecular tests outside clinical settings. Products include cassettes, strips, and test panels for applications spanning pregnancy detection, infectious disease screening, diabetes monitoring, and drug abuse testing. Distribution occurs through hospital pharmacies, retail outlets, and e-commerce platforms, serving consumers seeking convenient, private, rapid diagnostic solutions.

Market Growth Drivers

Rising demand for rapid, accurate, decentralized diagnostic solutions and self-testing convenience. Technological advancements in molecular assays including improved sensitivity and simplified workflows. Increasing prevalence of infectious diseases, chronic conditions, and reproductive health monitoring needs. Growing consumer preference for privacy, faster results, and reduced healthcare facility visits.

Market Restraints

High test kit costs and limited reimbursement coverage restricting affordability in price-sensitive markets. Regulatory complexity and lengthy approval timelines increasing compliance burdens for manufacturers. Limited consumer awareness and concerns regarding test accuracy and proper sample collection methods.

Market Opportunities

Integration with digital health ecosystems, telemedicine platforms, and mobile health applications. Expansion into emerging markets through e-commerce infrastructure and government-supported decentralized healthcare. Development of cost-effective assay chemistries and simplified device formats for broader market penetration.

Key Questions Answered in the Report

- What are the major factors driving global demand for at-home molecular testing?
- Which product segments and applications are fueling At-Home Molecular Testing market growth?
- How is North America, 48.5% shaping the At-Home Molecular Testing market landscape?
- Who are the leading players in the at-home molecular testing market, and what strategies are they adopting?
- What are the emerging trends and long-term growth prospects for the global At-Home Molecular Testing market?

Competitive Intelligence and Business Strategy

Leading players in the at-home molecular testing market are focusing on capacity expansion, product innovation, and strategic partnerships to strengthen their global footprint. Investments in advanced technologies and vertical integration help ensure consistent product quality and supply reliability. Companies are also prioritizing long-term customer relationships and geographic expansion, while emphasizing sustainability, operational efficiency, and cost optimization to gain a competitive edge.

Key Companies Profiled

- Abbott
- ACON Laboratories, Inc.
- Becton and Dickinson
- Cardinal Health
- B. Braun Melsungen AG
- Piramal Enterprises Ltd.
- F. Hoffmann-La Roche Ltd
- Quidel Corporation
- Bionime Corporation
- SA Scientific
- ARKRAY USA, Inc.
- Nova Biomedical
- AdvaCare Pharma
- Co-Diagnostics, Inc.

Market Segmentation

By Product Type
- Cassettes
- Strips
- Test Panels
- Dip Cards
- Midstream
- Others

By Test Type
- Pregnancy Tests
- HIV Tests
- Diabetes
- Infectious Diseases
- Glucose Tests
- Ovulation Predictor Tests
- Drug Abuse Tests
- Others

By Sample Type
- Urine
- Blood
- Saliva
- Others

By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others

By Region
- North America
- Europe
- East Asia
- South Asia & Oceania
- Latin America
- Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global At-Home Molecular Testing Market Snapshot, 2026 and 2033
1.2. Market Opportunity Assessment, 2026-2033, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Product Lifecycle Analysis
2.4. At-Home Molecular Testing Market: Value Chain
2.4.1. List of Raw Material Suppliers
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. Profitability Analysis
2.5. Forecast Factors - Relevance and Impact
2.6. Covid-19 Impact Assessment
2.7. PESTLE Analysis
2.8. Porter Five Force’s Analysis
2.9. Geopolitical Tensions: Market Impact
2.10. Regulatory and Application Landscape
3. Macro-Economic Factors
3.1. Global Sectorial Outlook
3.2. Global GDP Growth Outlook
3.3. Global Parent Market Overview
4. Price Trend Analysis, 2020 - 2033
4.1. Key Highlights
4.2. Key Factors Impacting Product Prices
4.3. Prices By Product Type/Composition/Application
4.4. Regional Prices and Product Preferences
5. Global At-Home Molecular Testing Market Outlook: Historical (2020-2025) and Forecast (2026-2033)
5.1. Key Highlights
5.1.1. Market Size and Y-o-Y Growth
5.1.2. Absolute $ Opportunity
5.2. Market Size (US$ Mn) Analysis and Forecast
5.2.1. Historical Market Size Analysis, 2020-2025
5.2.2. Current Market Size Forecast, 2026-2033
5.3. Global At-Home Molecular Testing Market Outlook: Product Type
5.3.1. Introduction / Key Findings
5.3.2. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2020-2025
5.3.3. Current Market Size (US$ Mn) and Volume Forecast By Product Type, 2026-2033
5.3.3.1. Cassettes
5.3.3.2. Strips
5.3.3.3. Test Panels
5.3.3.4. Dip Cards
5.3.3.5. Midstream
5.3.3.6. Others
5.4. Market Attractiveness Analysis: Product Type
5.5. Global At-Home Molecular Testing Market Outlook: Test Type
5.5.1. Introduction / Key Findings
5.5.2. Historical Market Size (US$ Mn) and Volume Analysis By Test Type, 2020-2025
5.5.3. Current Market Size (US$ Mn) and Volume Forecast By Test Type, 2026-2033
5.5.3.1. Pregnancy Tests
5.5.3.2. HIV Tests
5.5.3.3. Diabetes
5.5.3.4. Infectious Diseases
5.5.3.5. Glucose Tests
5.5.3.6. Ovulation Predictor Tests
5.5.3.7. Drug Abuse Tests
5.5.3.8. Others
5.6. Market Attractiveness Analysis: Test Type
6. Global At-Home Molecular Testing Market Outlook: Region
6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2020-2025
6.3. Current Market Size (US$ Mn) and Volume Forecast By Region, 2026-2033
6.3.1. North America
6.3.2. Europe
6.3.3. East Asia
6.3.4. South Asia & Oceania
6.3.5. Latin America
6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region
7. North America At-Home Molecular Testing Market Outlook: Historical (2020-2025) and Forecast (2026-2033)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
7.3.1. By Country
7.3.2. By Product Type
7.3.3. By Test Type
7.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
7.4.1. U.S.
7.4.2. Canada
7.5. Current Market Size (US$ Mn) and Volume Forecast By Product Type, 2026-2033
7.5.1. Cassettes
7.5.2. Strips
7.5.3. Test Panels
7.5.4. Dip Cards
7.5.5. Midstream
7.5.6. Others
7.6. Current Market Size (US$ Mn) and Volume Forecast By Test Type, 2026-2033
7.6.1. Pregnancy Tests
7.6.2. HIV Tests
7.6.3. Diabetes
7.6.4. Infectious Diseases
7.6.5. Glucose Tests
7.6.6. Ovulation Predictor Tests
7.6.7. Drug Abuse Tests
7.6.8. Others
7.7. Market Attractiveness Analysis
8. Europe At-Home Molecular Testing Market Outlook: Historical (2020-2025) and Forecast (2026-2033)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
8.3.1. By Country
8.3.2. By Product Type
8.3.3. By Test Type
8.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
8.4.1. Germany
8.4.2. France
8.4.3. U.K.
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Rest of Europe
8.5. Current Market Size (US$ Mn) and Volume Forecast By Product Type, 2026-2033
8.5.1. Cassettes
8.5.2. Strips
8.5.3. Test Panels
8.5.4. Dip Cards
8.5.5. Midstream
8.5.6. Others
8.6. Current Market Size (US$ Mn) and Volume Forecast By Test Type, 2026-2033
8.6.1. Pregnancy Tests
8.6.2. HIV Tests
8.6.3. Diabetes
8.6.4. Infectious Diseases
8.6.5. Glucose Tests
8.6.6. Ovulation Predictor Tests
8.6.7. Drug Abuse Tests
8.6.8. Others
8.7. Market Attractiveness Analysis
9. East Asia At-Home Molecular Testing Market Outlook: Historical (2020-2025) and Forecast (2026-2033)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Test Type
9.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
9.4.1. China
9.4.2. Japan
9.4.3. South Korea
9.5. Current Market Size (US$ Mn) and Volume Forecast By Product Type, 2026-2033
9.5.1. Cassettes
9.5.2. Strips
9.5.3. Test Panels
9.5.4. Dip Cards
9.5.5. Midstream
9.5.6. Others
9.6. Current Market Size (US$ Mn) and Volume Forecast By Test Type, 2026-2033
9.6.1. Pregnancy Tests
9.6.2. HIV Tests
9.6.3. Diabetes
9.6.4. Infectious Diseases
9.6.5. Glucose Tests
9.6.6. Ovulation Predictor Tests
9.6.7. Drug Abuse Tests
9.6.8. Others
9.7. Market Attractiveness Analysis
10. South Asia & Oceania At-Home Molecular Testing Market Outlook: Historical (2020-2025) and Forecast (2026-2033)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Test Type
10.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
10.4.1. India
10.4.2. Southeast Asia
10.4.3. ANZ
10.4.4. Rest of South Asia & Oceania
10.5. Current Market Size (US$ Mn) and Volume Forecast By Product Type, 2026-2033
10.5.1. Cassettes
10.5.2. Strips
10.5.3. Test Panels
10.5.4. Dip Cards
10.5.5. Midstream
10.5.6. Others
10.6. Current Market Size (US$ Mn) and Volume Forecast By Test Type, 2026-2033
10.6.1. Pregnancy Tests
10.6.2. HIV Tests
10.6.3. Diabetes
10.6.4. Infectious Diseases
10.6.5. Glucose Tests
10.6.6. Ovulation Predictor Tests
10.6.7. Drug Abuse Tests
10.6.8. Others
10.7. Market Attractiveness Analysis
11. Latin America At-Home Molecular Testing Market Outlook: Historical (2020-2025) and Forecast (2026-2033)
11.1. Key Highlights
11.2. Pricing Analysis
11.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Test Type
11.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Rest of Latin America
11.5. Current Market Size (US$ Mn) and Volume Forecast By Product Type, 2026-2033
11.5.1. Cassettes
11.5.2. Strips
11.5.3. Test Panels
11.5.4. Dip Cards
11.5.5. Midstream
11.5.6. Others
11.6. Current Market Size (US$ Mn) and Volume Forecast By Test Type, 2026-2033
11.6.1. Pregnancy Tests
11.6.2. HIV Tests
11.6.3. Diabetes
11.6.4. Infectious Diseases
11.6.5. Glucose Tests
11.6.6. Ovulation Predictor Tests
11.6.7. Drug Abuse Tests
11.6.8. Others
11.7. Market Attractiveness Analysis
12. Middle East & Africa At-Home Molecular Testing Market Outlook: Historical (2020-2025) and Forecast (2026-2033)
12.1. Key Highlights
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Test Type
12.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
12.4.1. GCC
12.4.2. South Africa
12.4.3. Northern Africa
12.4.4. Rest of Middle East & Africa
12.5. Current Market Size (US$ Mn) and Volume Forecast By Product Type, 2026-2033
12.5.1. Cassettes
12.5.2. Strips
12.5.3. Test Panels
12.5.4. Dip Cards
12.5.5. Midstream
12.5.6. Others
12.6. Current Market Size (US$ Mn) and Volume Forecast By Test Type, 2026-2033
12.6.1. Pregnancy Tests
12.6.2. HIV Tests
12.6.3. Diabetes
12.6.4. Infectious Diseases
12.6.5. Glucose Tests
12.6.6. Ovulation Predictor Tests
12.6.7. Drug Abuse Tests
12.6.8. Others
12.7. Market Attractiveness Analysis
13. Competition Landscape
13.1. Market Share Analysis, 2025
13.2. Market Structure
13.2.1. Competition Intensity Mapping By Market
13.2.2. Competition Dashboard
13.2.3. Apparent Production/Service Capacity
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
13.3.1. Abbott
13.3.1.1. Overview
13.3.1.2. Segments and Products
13.3.1.3. Key Financials
13.3.1.4. Market Developments
13.3.1.5. Market Strategy
13.3.2. ACON Laboratories, Inc.
13.3.3. Becton and Dickinson
13.3.4. Cardinal Health
13.3.5. B. Braun Melsungen AG
13.3.6. Piramal Enterprises Ltd.
13.3.7. F. Hoffmann-La Roche Ltd
13.3.8. Quidel Corporation
13.3.9. Bionime Corporation
13.3.10. SA Scientific
13.3.11. ARKRAY USA, Inc.
13.3.12. Nova Biomedical
13.3.13. AdvaCare Pharma
13.3.14. Co-Diagnostics, Inc.
14. Appendix
14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations